Postmarketing surveillance of potentially fatal reactions to oncology drugs: potential utility of two signal-detection algorithms-Reference-Cited by-同舟云学术

Postmarketing surveillance of potentially fatal reactions to oncology drugs: potential utility of two signal-detection algorithms

Published:2004-11-17 Issue:10 Volume:60 Page:747-750
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Hauben Manfred,Reich Lester,Chung Stephanie

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-004-0834-0.pdf

Reference12 articles.

1. DuMouchel W (1999) Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat 53(3):177?190

2. Evans SJW, Waller PC, Davis S (2001) Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 10(6):483?486

3. Follman M, Michel A (2003) Proportional reporting ratios for signal detection in the drug safety database of a pharmaceutical company. Pharmacoepidemiol Drug Saf 12(suppl 1):S171

4. Gould AL (2003) Practical pharmacovigilance analysis strategies. Pharmacoepidemiol Drug Saf 12(7):559?574

5. Hauben M (2003) A brief primer on automated signal detection. Ann Pharmacother 37(7/8):1117?1123

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Real-World Pharmacovigilance Study of Ceftazidime/avibactam: Data Mining of the FDA Adverse Event Reporting System (FAERS) Database;2024-01-10

2. Evolution of Hematology Clinical Trial Adverse Event Reporting to Improve Care Delivery;Current Hematologic Malignancy Reports;2021-03-30

3. Hepatitis B infection reported with cancer chemotherapy: analyzing the US FDA Adverse Event Reporting System;Cancer Medicine;2018-04-16

4. The impact of database restriction on pharmacovigilance signal detection of selected cancer therapies;Therapeutic Advances in Drug Safety;2017-02-01

5. Improving drug safety: From adverse drug reaction knowledge discovery to clinical implementation;Methods;2016-11